Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06647082 · ClinicalTrials.gov registry record · NA
Engaging Kids With Robotic Exoskeletons and Gamification
A NA study, sponsored by Georgia Institute of Technology.
- Not yet
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT06647082: Clinical Trial NA study, sponsored by Georgia Institute of Technology.
NCT06647082 is a NA study that has not yet begun recruiting, run by Georgia Institute of Technology. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06647082, a NA study, has not yet begun recruiting, sponsored by Georgia Institute of Technology.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Conduct a clinical field trial at CHOA's Day Rehab Program using the clinical exoskeleton in conjunction with visual biofeedback with pediatric patients who present with genu recurvatum or crouch gait over 5 rehabilitation visits.
Primary Outcome
The participant walks a 10 meter distance while their speed is recorded. Higher speeds are indicative of a more positive outcome.
Interventions
- DEVICE Pediatric Knee Exoskeleton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2026-09-30 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
What is known before NCT06647082 opens enrollment
NCT06647082 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Pediatric Knee Exoskeleton is the first listed.
NCT06647082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06647082 about?
NCT06647082 is a clinical study titled "Engaging Kids With Robotic Exoskeletons and Gamification". Conduct a clinical field trial at CHOA's Day Rehab Program using the clinical exoskeleton in conjunction with visual biofeedback with pediatric patients who present with genu recurvatum or crouch gait over 5 rehabilitation visits.
What is the current status of trial NCT06647082?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2026-09-30. Estimated completion is 2027-12-30.
What interventions are being tested in trial NCT06647082?
The interventions under investigation include: Pediatric Knee Exoskeleton (DEVICE).
Who is sponsoring clinical trial NCT06647082?
This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06647082's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI